Survodutide for Obesity: Systematic Review of the GLP-1/Glucagon Dual Agonist
Systematic review of survodutide efficacy and safety for obesity consolidates evidence for this dual GLP-1/glucagon agonist approaching clinical use.
Quick Facts
What This Study Found
Systematic review of survodutide efficacy and safety for obesity consolidates evidence for this dual GLP-1/glucagon agonist approaching clinical use.
Key Numbers
How They Did This
In publication.
Why This Research Matters
Relevant to peptide therapeutics.
The Bigger Picture
Advances peptide evidence.
What This Study Doesn't Tell Us
In publication.
Questions This Raises
- ?Long-term implications?
- ?Evidence comparison?
- ?Next steps?
Trust & Context
- Key Stat:
- Key finding Systematic review of survodutide efficacy and safety for obesity consolidates evidence for this dual
- Evidence Grade:
- Based on design.
- Study Age:
- Published in 2025.
- Original Title:
- Evaluating the efficacy and safety of survodutide for obesity: a systematic review and meta-analysis of randomized controlled trials.
- Published In:
- Proceedings (Baylor University. Medical Center), 38(4), 514-522 (2025)
- Authors:
- Awad, Abdelaziz A, Abdrabou Abouelmagd, Alaa(2), Mohammed, Fatma, Elettreby, Abdelrahman M, Mahmoud Marey, Mohamed, Aldemerdash, Mohamed A, Soliman, Samar M, Belal, Mohamed Mohamed, Abosheaishaa, Hazem
- Database ID:
- RPEP-10023
Evidence Hierarchy
Frequently Asked Questions
What does this mean?
Systematic review of survodutide efficacy and safety for obesity consolidates evidence for this dual GLP-1/glucagon agonist approaching clinical use.
How reliable?
Consult publication.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-10023APA
Awad, Abdelaziz A; Abdrabou Abouelmagd, Alaa; Mohammed, Fatma; Elettreby, Abdelrahman M; Mahmoud Marey, Mohamed; Aldemerdash, Mohamed A; Soliman, Samar M; Belal, Mohamed Mohamed; Abosheaishaa, Hazem. (2025). Evaluating the efficacy and safety of survodutide for obesity: a systematic review and meta-analysis of randomized controlled trials.. Proceedings (Baylor University. Medical Center), 38(4), 514-522. https://doi.org/10.1080/08998280.2025.2480512
MLA
Awad, Abdelaziz A, et al. "Evaluating the efficacy and safety of survodutide for obesity: a systematic review and meta-analysis of randomized controlled trials.." Proceedings (Baylor University. Medical Center), 2025. https://doi.org/10.1080/08998280.2025.2480512
RethinkPeptides
RethinkPeptides Research Database. "Evaluating the efficacy and safety of survodutide for obesit..." RPEP-10023. Retrieved from https://rethinkpeptides.com/research/awad-2025-evaluating-the-efficacy-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.